Patients’ Views on the Design of DiabeText, a New mHealth Intervention to Improve Adherence to Oral Antidiabetes Medication in Spain: A Qualitative Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Participants
2.2. Data Collection
- We know that you all have diabetes. We wanted to start by asking: what do you do to care for and control sugar?
- What do you need to do to have sugar under control?
- What is more difficult for you to control?
- What are the things that help you? What works best for you?
- Regarding the recommendations on diet, what difficulties do you have in carrying out an adequate diet that helps you control your disease? What helps you overcome or face these difficulties?
- Regarding physical exercise, what difficulties do you have to carry out a level of physical exercise that helps you control your disease? What helps you overcome or face these difficulties?
- Regarding the diabetes medication, what do you think about diabetes medication? (Explore knowledge and beliefs on antidiabetic medication.) What difficulties do you have in taking the medication as prescribed by your doctor? What helps you overcome or face these difficulties?
- In general terms, what do you think of the idea of receiving SMS to your mobile phones with information that can help you take care of your diabetes?
- To what extent do you think it could be useful in your day-to-day life, as a tool to try to solve some of the problems you mentioned earlier?
- Do you have access to mobile phones?
- Do you see any problem accessing the text messages that we could send to your phones?
- In general, what aspects do you think we should take into account when starting this service, so that it has the best possible acceptance from patients?
- Would you prefer to receive the information in some other format other than SMS (audio, images or others)?
- What content do you think these messages should include?
- What are your preferences regarding:
- ◦
- the language of the messages?
- ◦
- the frequency of messages?
- ◦
- the level of personalisation? (e.g., patient’s name)
- ◦
- the ability for patients to customise the type of message that they want to receive? (content, frequency, language, time of day)
- Any other ideas or suggestions?
2.3. Data Analysis
3. Results
3.1. Patients’ Perspectives on Unmet Needs for DSM
3.1.1. Lack of Appropriate Information Is the Key Barrier for DSM
“What do I need to take? What type of insulin? What do I need to do? He [the primary care doctor] didn’t give me any damn kind of information”.(Man, 59, without higher education.)
“You need to keep up to date with the advances in medication and with the techniques concerning that. If you don’t, the general practitioner gives you the same medication for ten years”.(Man, 60, with higher education.)
“That’s the problem with diabetes, it doesn’t hurt, nothing happens (…) you don’t feel physical pain, and that’s the problem. You just get comfortable with it and then whoops!”(Man, 53, with higher education.)
3.1.2. Support with Medication Is Not Perceived as a Need, despite Existing Multiple Barriers for Medication-Taking
“I do carry my pill box, but there are far more things, like inhalers. There are just too many things and my memory just fails me…”.(Man, <65 years old, without higher education.)
“Some people are very reluctant to take the medication due to the amount, the contraindications and other problems. (…) they’ll only take their medication when there’s an emergency”.(Woman, 66, with higher education.)
“I don’t believe that many pills are actually good”.(Man, 60, with higher education.)
3.1.3. Support with Diet and Physical Activity Is Perceived as Important and Demanded
“I go to the supermarkets and ask for the diabetic products, but no one knows anything to help me with my diet”.(Woman, 74, without higher education.)
“You may follow a strict diet (…) everything boiled, a chicken breast, etc., and you may cure your diabetes… But you will end up mad. You may end up with depression. (…) And then, well, you meet up with your friends and you can’t give up having a beer. So I don’t want to have any stigma. The pill and that’s it”.(Man, 63, with higher education.)
“I have a question: Does it matter if you walk in the morning or in the afternoon? Is the point just to walk or is there a better time of the day? I ask because the strong meals usually happen during the day, so if you want to burn them, does it matter if you do so in the morning or in the evening?”(Woman, 55, without higher education.)
3.2. Participants’ Acceptability and Perceived Utility of the DiabeText Text Messaging Intervention
3.2.1. The Proposed Messaging System Is Acceptable and Perceived as Useful for DSM
“If I were told something about it, I would not eat sweets that day”.(Woman, 72, without higher education.)
“Helpful? No, not for me. Although it could be useful for older people, like for my mother. She needs to take her medication at 6 p.m., but if her alarm for the medication doesn’t go off at that time, I believe it could be 8 p.m. and she would have forgotten to take it”.(Woman, 46, without higher education.)
“I have a nice scale app that informs me about my weight, fat index, body mass… Because your diabetes decreases if you’re healthy. (…) I have that information in my phone so I can keep track of it.(Man, 60, with higher education.)
“I don’t know how to use the phone. They gave me a list with the information I need if I need to call my daughter or my son. I just need to click where it says so and that’s it”.(Woman, 75, without higher education.)
3.2.2. Specific Characteristics of the System That May Enhance the Usefulness of DiabeText
“Text messages should be simple and clear like a manual”.(Man, 60, with higher education.)
“I believe it would be a good idea if you could answer to that information. (…) I believe that would be a positive aspect”.(Man, 53, with higher education.)
4. Discussion
Strengths and Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Acknowledgments
Conflicts of Interest
References
- International Diabetes Federation. IDF Diabetes Atlas, 10th ed.; International Diabetes Federation: Brussels, Belgium, 2021. [Google Scholar]
- Kaiser, A.B.; Zhang, N.; Der Plujim, W. Van Global Prevalence of Type 2 Diabetes over the Next Ten Years (2018–2028). Diabetes 2018, 67, 202-LB. [Google Scholar] [CrossRef]
- Hertz, R.P.; Unger, A.N.; Lustik, M.B. Adherence with pharmacotherapy for type 2 diabetes: A retrospective cohort study of adults with employer-sponsored health insurance. Clin. Ther. 2005, 27, 1064–1073. [Google Scholar] [CrossRef]
- Saini, S.D.; Schoenfeld, P.; Kaulback, K.; Dubinsky, M.C. Effect of medication dosing frequency on adherence in chronic diseases. Am. J. Manag. Care 2009, 15, e22–e33. [Google Scholar] [PubMed]
- De León, A.C.; Del Castillo Rodríguez, J.C.; Coello, S.D.; Del Cristo Rodríguez Pérez, M.; Díaz, B.B.; Álamo, C.B.; Fernández, L.C.; González, D.A.; Sánchez, J.J.A.; Hernández, A.G.; et al. Lifestyle and treatment adherence of type 2 diabetes mellitus people in the Canary Islands. Rev. Esp. Salud Publica 2009, 83, 567–575. Available online: https://pubmed.ncbi.nlm.nih.gov/19893884/ (accessed on 4 March 2021).
- Gutiérrez-Angulo, M.L.; Lopetegi-Uranga, P.; Sánchez-Martín, I.; Garaigordobil-Landazabal, M. Therapeutic compliance in patients with arterial hypertension and type 2 diabetes mellitus. Rev. Calid. Asist. 2012, 27, 72–77. [Google Scholar] [CrossRef]
- López-Simarro, F.; Brotons, C.; Moral, I.; Cols-Sagarra, C.; Selva, A.; Aguado-Jodar, A.; Miravet-Jiménez, S. Inertia and treatment compliance in patients with type 2 diabetes in primary care. Med. Clin. 2012, 138, 377–384. [Google Scholar] [CrossRef]
- Márquez Contreras, E.; Martell Claros, N.; Gil Guillén, V.; Casado Martínez, J.J.; Martín De Pablos, J.L.; Ferraro García, J.; Chaves González, R.; Fernández Ortega, A. Therapeutic non-compliance with insulin in the treatment of diabetes mellitus 2. Aten. Primaria 2012, 44, 74–81. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Piñeiro, F.; Gil, V.; Donis, M.; Orozco, D.; Pastor, R.; Merino, J. The validity of 6 indirect methods for assessing drug treatment compliance in arterial hypertension. Aten. Primaria 1997, 19, 465–468. [Google Scholar] [PubMed]
- Piñeiro, F.; Gil, V.; Donis, M.; Orozco, D.; Pastor, R.; Merino, J. Relationship between medical treatment compliance and the degree of control in patients with high blood pressure, non-insulin dependent diabetes mellitus and dyslipidemia. Med. Clin. 1998, 111, 565–567. [Google Scholar]
- Gil-Girbau, M.; Aznar-Lou, I.; Peñarrubia-María, M.T.; Moreno-Peral, P.; Fernández, A.; Bellón, J.; Jové, A.M.; Mendive, J.; Fernández-Vergel, R.; Figueiras, A.; et al. Reasons for medication non-initiation: A qualitative exploration of the patients’ perspective. Res. Soc. Adm. Pharm. 2020, 16, 663–672. [Google Scholar] [CrossRef] [PubMed]
- Farmer, A.J.; McSharry, J.; Rowbotham, S.; McGowan, L.; Ricci-Cabello, I.; French, D.P. Effects of interventions promoting monitoring of medication use and brief messaging on medication adherence for people with Type 2 diabetes: A systematic review of randomized trials. Diabet Med. 2016, 33, 565–579. [Google Scholar] [CrossRef] [PubMed]
- Arambepola, C.; Ricci-Cabello, I.; Manikavasagam, P.; Roberts, N.; French, D.P.; Farmer, A. The Impact of Automated Brief Messages Promoting Lifestyle Changes Delivered Via Mobile Devices to People with Type 2 Diabetes: A Systematic Literature Review and Meta-Analysis of Controlled Trials. J. Med. Internet Res. 2016, 18, e86. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Haider, R.; Sudini, L.; Chow, C.K.; Cheung, N.W. Mobile phone text messaging in improving glycaemic control for patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Res. Clin. Pract. 2019, 150, 27–37. [Google Scholar] [CrossRef] [PubMed]
- Sahin, C.; Courtney, K.L.; Naylor, P.J.; Rhodes, E.R. Tailored mobile text messaging interventions targeting type 2 diabetes self-management: A systematic review and a meta-analysis. Digit. Health 2019, 5, 2055207619845279. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Faruque, L.I.; Wiebe, N.; Ehteshami-Afshar, A.; Liu, Y.; Dianati-Maleki, N.; Hemmelgarn, B.R.; Manns, B.J.; Tonelli, M.; Alberta Kidney Disease, N. Effect of telemedicine on glycated hemoglobin in diabetes: A systematic review and meta-analysis of randomized trials. CMAJ 2017, 189, E341–E364. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, S.W.H.; Chan, C.K.Y.; Chua, S.S.; Chaiyakunapruk, N. Comparative effectiveness of telemedicine strategies on type 2 diabetes management: A systematic review and network meta-analysis. Sci. Rep. 2017, 7, 12680. [Google Scholar] [CrossRef]
- Shan, R.; Sarkar, S.; Martin, S.S. Digital health technology and mobile devices for the management of diabetes mellitus: State of the art. Diabetologia 2019, 62, 877–887. [Google Scholar] [CrossRef] [Green Version]
- Craig, P.; Dieppe, P.; Macintyre, S.; Mitchie, S.; Nazareth, I.; Petticrew, M. Developing and evaluating complex interventions: The new Medical Research Council guidance. BMJ 2008, 337, 979–983. [Google Scholar] [CrossRef] [Green Version]
- Ricci-Cabello, I.; Bobrow, K.; Islam, S.M.S.; Chow, C.K.; Maddison, R.; Whittaker, R.; Farmer, A.J. Examining Development Processes for Text Messaging Interventions to Prevent Cardiovascular Disease: Systematic Literature Review. JMIR mHealth uHealth 2019, 7, e12191. [Google Scholar] [CrossRef] [Green Version]
- Vluggen, S.; Hoving, C.; Schaper, N.C.; De Vries, H. Psychological predictors of adherence to oral hypoglycaemic agents: An application of the ProMAS questionnaire. Psychol. Health 2020, 35, 387–404. [Google Scholar] [CrossRef]
- Jankowska-Polańska, B.; Świątoniowska-Lonc, N.; Karniej, P.; Polański, J.; Tański, W.; Grochans, E. Influential factors in adherence to the therapeutic regime in patients with type 2 diabetes and hypertension. Diabetes Res. Clin. Pract. 2021, 173, 108693. [Google Scholar] [CrossRef]
- Gedik, S.; Kocoglu, D. Self-efficacy level among patients with type 2 diabetes living in rural areas. Rural Remote Health 2018, 18, 4262. [Google Scholar] [CrossRef] [Green Version]
- Abdullah, A.; Liew, S.M.; Salim, H.; Ng, C.J.; Chinna, K. Prevalence of limited health literacy among patients with type 2 diabetes mellitus: A systematic review. PLoS ONE 2019, 14, e0216402. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Luo, X.; Liu, T.; Yuan, X.; Ge, S.; Yang, J.; Li, C.; Sun, W. Factors Influencing Self-Management in Chinese Adults with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health 2015, 12, 11304–11327. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wilkinson, S. Focus group research. Qual. Res. Theory Method Pract. 2004, 2, 177–199. [Google Scholar]
- Pope, C.; Ziebland, S.; Mays, N. Analysing qualitative data. BMJ Books 2000, 320, 114–116. [Google Scholar] [CrossRef]
- Braun, V.; Clarke, V. Using thematic analysis in psychology. Qual. Res. Psychol. 2006, 3, 77–101. [Google Scholar] [CrossRef] [Green Version]
- Mira, J.J.; Guilabert, M.; Perez-Jover, V.; Lorenzo, S. Barriers for an effective communication around clinical decision making: An analysis of the gaps between doctors’ and patients’ point of view. Health Expect 2014, 17, 826–839. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Moreno-Peral, P.; Conejo-Ceron, S.; Fernandez, A.; Berenguera, A.; Martinez-Andres, M.; Pons-Vigues, M.; Motrico, E.; Rodriguez-Martin, B.; Bellon, J.A.; Rubio-Valera, M. Primary care patients’ perspectives of barriers and enablers of primary prevention and health promotion-a meta-ethnographic synthesis. PLoS ONE 2015, 10, e0125004. [Google Scholar] [CrossRef]
- Duran, A.; Runkle, I.; Matía, P.; de Miguel, M.P.; Garrido, S.; Cervera, E.; Fernandez, M.D.; Torres, P.; Lillo, T.; Martin, P.; et al. Family physician and endocrinologist coordination as the basis for diabetes care in clinical practice. BMC Endocr. Disord. 2008, 8, 9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lopez-Bastida, J.; Boronat, M.; Moreno, J.O.; Schurer, W. Costs, outcomes and challenges for diabetes care in Spain. Global. Health 2013, 9, 17. [Google Scholar] [CrossRef] [Green Version]
- Artola Menéndez, S.; Rovira Loscos, A.; Ricart, W. Multidisciplinary coordination in the approach to type 2 diabetes mellitus. Med. Clin. 2010, 135, 27–32. [Google Scholar] [CrossRef]
- Gérvas, J. Case and disease management and improved integration of healthcare services in Spain. 2008 SESPAS report. Gac. Sanit. 2008, 22, 163–168. [Google Scholar] [CrossRef] [Green Version]
- Bernal-Delgado, E.; Garcia-Armesto, S.; Oliva, J.; Sanchez Martinez, F.I.; Repullo, J.R.; Pena-Longobardo, L.M.; Ridao-Lopez, M.; Hernandez-Quevedo, C. Spain: Health System Review. Health Syst Transit 2018, 20, 1–179. [Google Scholar]
- Brito, N.B.; Célix, M.S.; Jiménez, O.M.; García, L.C.; Trenco, P.Á. Situación del Dietista-Nutricionista en el Sistema Nacional de Salud Español: Documento de posicionamiento del Grupo de Especialización en Nutrición Clínica y Dietética de la Academia Española de Nutrición y Dietética. Rev. Española Nutr. Hum. Dietética 2020, 24, 278–288. [Google Scholar] [CrossRef]
- Echeburúa, E.; Salaberría, K.; de Corral, P.; Cruz-Sáez, S. Funciones y ámbitos de actuación del psicólogo clínico y del psicólogo general sanitario: Una primera reflexión. Behav. Psychol. Psicol. Conduct. 2012, 20, 423–435. [Google Scholar]
- Sirera, J.P. El psicólogo en atención primaria: Un debate necesario en el sistema nacional de salud. Papeles Psicol. 2008, 29, 281–290. [Google Scholar]
- Rubio, J.A.; Aragón-Sánchez, J.; Lázaro-Martínez, J.L.; Almaraz, M.C.; Mauricio, D.; Antolín Santos, J.B.; Díaz Pérez, J.Á.; Fabbi, M.; Lozano Del Hoyo, M.L.; Vela, M.P. Diabetic foot units in Spain: Knowing the facts using a questionnaire. Endocrinol. Nutr. 2014, 61, 79–86. [Google Scholar] [CrossRef] [PubMed]
- Bartlett, Y.K.; Newhouse, N.; Long, H.A.; Farmer, A.J.; French, D.P. What do people with type 2 diabetes want from a brief messaging system to support medication adherence? Patient Prefer. Adherence 2019, 13, 1629–1640. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- McSharry, J.; McGowan, L.; Farmer, A.J.; French, D.P. Perceptions and experiences of taking oral medications for the treatment of Type 2 diabetes mellitus: A systematic review and meta-synthesis of qualitative studies. Diabet Med. 2016, 33, 1330–1338. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sanchez-Hernandez, M.S.; Rodriguez-Caldero, M.C.; Martin-Perez, M.P.; Mira-Solves, J.J.; Vitaller-Burillo, J.; Carratala-Munuera, M.C. Impact of adherence to Mediterranean diet and/or drug treatment on glycaemic control in type 2 diabetes mellitus patients: DM2-CUMCYL study. Prim. Care Diabetes 2020, 14, 685–691. [Google Scholar] [CrossRef] [PubMed]
- Krass, I.; Schieback, P.; Dhippayom, T. Adherence to diabetes medication: A systematic review. Diabet Med. 2015, 32, 725–737. [Google Scholar] [CrossRef]
- Moyano, D.; Morelli, D.; Santero, M.; Belizan, M.; Irazola, V.; Beratarrechea, A. Perceptions and Acceptability of Text Messaging for Diabetes Care in Primary Care in Argentina: Exploratory Study. JMIR Diabetes 2019, 4, e10350. [Google Scholar] [CrossRef]
- Nelson, L.A.; Mulvaney, S.A.; Johnson, K.B.; Osborn, C.Y. mHealth Intervention Elements and User Characteristics Determine Utility: A Mixed-Methods Analysis. Diabetes Technol. Ther. 2017, 19, 9–17. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Turnbull, S.; Lucas, P.J.; Hay, A.D.; Cabral, C. The role of economic, educational and social resources in supporting the use of digital health technologies by people with T2D: A qualitative study. BMC Public Health 2021, 21, 12. [Google Scholar] [CrossRef] [PubMed]
- Mahou, X.; Barral, B.; Fernández, Á.; Bouzas-Lorenzo, R.; Cernadas, A. eHealth and mHealth Development in Spain: Promise or Reality? Int. J. Environ. Res. Public Health 2021, 18, 13055. [Google Scholar] [CrossRef]
- Sekhon, M.; Cartwright, M.; Francis, J.J. Acceptability of healthcare interventions: An overview of reviews and development of a theoretical framework. BMC Health Serv. Res. 2017, 17, 88. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Prinjha, S.; Ricci-Cabello, I.; Newhouse, N.; Farmer, A. British South Asian Patients’ Perspectives on the Relevance and Acceptability of Mobile Health Text Messaging to Support Medication Adherence for Type 2 Diabetes: Qualitative Study. JMIR mHealth uHealth 2020, 8, e15789. [Google Scholar] [CrossRef]
- Lauffenburger, J.C.; Barlev, R.A.; Sears, E.S.; Keller, P.A.; McDonnell, M.E.; Yom-Tov, E.; Fontanet, C.P.; Hanken, K.; Haff, N.; Choudhry, N.K. Preferences for mHealth Technology and Text Messaging Communication in Patients With Type 2 Diabetes: Qualitative Interview Study. J. Med. Internet Res. 2021, 23, e25958. [Google Scholar] [CrossRef] [PubMed]
- Chi, Y.; Velardo, C.; Allen, J.; Robinson, S.; Riga, E.; Judge, D.; Tarassenko, L.; Farmer, A.J. System architecture for “Support through mobile messaging and digital health technology for diabetes” (SuMMiT-D): Design and performance in pilot and randomized controlled feasibility studies. JMIR Form. Res. 2021, 5, e18460. [Google Scholar] [CrossRef]
- Elo, S.; Kääriäinen, M.; Kanste, O.; Pölkki, T.; Utriainen, K.; Kyngäs, H. Qualitative Content Analysis: A Focus on Trustworthiness. SAGE Open 2014, 4, 215824401452263. [Google Scholar] [CrossRef]
Groups | Number of Participants | Gender Distribution (Male/Female) | Age Range (Years) | Focus Group Duration (Minutes) |
---|---|---|---|---|
Aged < 65; without higher education | 10 | 6/4 | 46–64 | 63 |
Aged ≥ 65; without higher education | 8 | 5/3 | 68–74 | 66 |
Aged < 65; with higher education | 9 | 6/3 | 43–63 | 73 |
Aged ≥ 65; with higher education | 7 | 4/3 | 66–75 | 55 |
Barriers | Enablers | |
---|---|---|
Overall management |
|
|
Medication |
|
|
Diet |
|
|
Physical activity |
|
|
T2DM complications |
|
|
Characteristics of Messages | Participants’ Opinion |
---|---|
Language |
|
Comprehension | Clear Short |
Tone | Positive Motivating |
Frequency | Every day Three to five times per week Once a month |
Time of day | Early in the morning Avoid working hours Not at night |
Level of personalisation | Physical activity level Frequency of messages Recipes Links for people with Internet on the mobile phone |
Other characteristics | Giving and receiving feedback through the system would be valuable Images would help to get the information in a better way |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zamanillo-Campos, R.; Serrano-Ripoll, M.J.; Taltavull-Aparicio, J.M.; Gervilla-García, E.; Ripoll, J.; Fiol-deRoque, M.A.; Boylan, A.-M.; Ricci-Cabello, I. Patients’ Views on the Design of DiabeText, a New mHealth Intervention to Improve Adherence to Oral Antidiabetes Medication in Spain: A Qualitative Study. Int. J. Environ. Res. Public Health 2022, 19, 1902. https://doi.org/10.3390/ijerph19031902
Zamanillo-Campos R, Serrano-Ripoll MJ, Taltavull-Aparicio JM, Gervilla-García E, Ripoll J, Fiol-deRoque MA, Boylan A-M, Ricci-Cabello I. Patients’ Views on the Design of DiabeText, a New mHealth Intervention to Improve Adherence to Oral Antidiabetes Medication in Spain: A Qualitative Study. International Journal of Environmental Research and Public Health. 2022; 19(3):1902. https://doi.org/10.3390/ijerph19031902
Chicago/Turabian StyleZamanillo-Campos, Rocío, Maria Jesús Serrano-Ripoll, Joana Maria Taltavull-Aparicio, Elena Gervilla-García, Joana Ripoll, Maria Antonia Fiol-deRoque, Anne-Marie Boylan, and Ignacio Ricci-Cabello. 2022. "Patients’ Views on the Design of DiabeText, a New mHealth Intervention to Improve Adherence to Oral Antidiabetes Medication in Spain: A Qualitative Study" International Journal of Environmental Research and Public Health 19, no. 3: 1902. https://doi.org/10.3390/ijerph19031902
APA StyleZamanillo-Campos, R., Serrano-Ripoll, M. J., Taltavull-Aparicio, J. M., Gervilla-García, E., Ripoll, J., Fiol-deRoque, M. A., Boylan, A. -M., & Ricci-Cabello, I. (2022). Patients’ Views on the Design of DiabeText, a New mHealth Intervention to Improve Adherence to Oral Antidiabetes Medication in Spain: A Qualitative Study. International Journal of Environmental Research and Public Health, 19(3), 1902. https://doi.org/10.3390/ijerph19031902